EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum Cytokine Profiling in Pancreatic Ductal Adenocarcinoma: A Pilot Study of Candidate Discriminators, Sex Differences and Altered Co-Regulation

Jesús García-Gómez iD, Samuel Agredano-Pérez, Diana Alejandra Rubio-Delgado iD, Adriana Aguilar-Lemarroy iD, Luis Felipe Jave-Suárez iD, Sarah Naomi Guevara-Hernández, Alejandro Bravo-Cuéllar iD, Aníbal Samael Méndez-Clemente iD, Georgina Hernández-Flores iD, María Martha Villaseñor-García iD

Biomolecules · 2026

DOI: 10.3390/biom16101492 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Jesús García-Gómez und 9 weiteren Autor:innen. Beteiligte Einrichtung: División de Inmunología, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalis…. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Cytokines, Pancreatic Neoplasms. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mexican Social Security Institute, Instituto Mexicano del Seguro Social.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is rarely detected before the disease is advanced, and existing serum markers are insufficient for early detection. Its systemic immune alterations are incompletely characterized and rarely examined by sex. We measured 19 serum cytokines by bead-based multiplex assay in 22 patients with PDAC and 16 controls, comparing groups overall and separately in women and men, and examined co-regulation among them. In the full cohort, interleukin-7 (IL-7) was the only cytokine to discriminate patients from controls after correction for multiple testing. Adjustment for age strengthened this association, and IL-7 matched the discrimination of carbohydrate antigen 19-9 (CA19-9). After stratification by sex, IL-7 remained the only cytokine higher in women, though it did not survive correction within that subgroup, whereas in men, eight innate, T-helper 17 (Th17) and type I interferon cytokines (IL-1α, IL-1RA, IL-31, IFN-α, IL-17A, IL-17F, TNF-α, and TNF-β) separated patients from controls, although the male control group was small. The correlation network present in controls was largely absent in patients, which instead showed few associations centered on IL-2, IL-5 and IL-6. These findings identify IL-7 as a candidate discriminator of PDAC and show that the cytokines separating patients from controls differed by sex, warranting validation in a larger, sex-balanced cohort that also measures sex hormones.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalCytokinesPancreatic NeoplasmsHumansMaleFemaleAgedPilot ProjectsMiddle AgedInterleukin-7Biomarkers, TumorSex CharacteristicsSex Factors

Stichwörter der Autor:innen

IL-7candidate markerscytokinesmultiplex immunoassaypancreatic ductal adenocarcinomasex differences

Substanzen

CytokinesInterleukin-7Biomarkers, Tumor

Autor:innen und Institutionen

  • División de Inmunología, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico.
  • Programa de Doctorado en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
  • Clínica de Tumores Gastrointestinales, Servicio de Oncología, Unidad Médica de Alta Especialidad, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico.
  • Hospital Regional de Alta Especialidad, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (IS-SSTE), Tlajomulco de Zúñiga 45640, Jalisco, Mexico.
  • Unidad de Investigación Epidemiológica y en Servicios de Salud, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico.
  • Programa de Doctorado en Microbiología Médica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.

ORCID-Profile: Jesús García-Gómez, Diana Alejandra Rubio-Delgado, Adriana Aguilar-Lemarroy, Luis Felipe Jave-Suárez, Alejandro Bravo-Cuéllar, Aníbal Samael Méndez-Clemente, Georgina Hernández-Flores, María Martha Villaseñor-García

Förderung

  • Mexican Social Security Institute
  • Instituto Mexicano del Seguro Social

Zitieren

APA

García-Gómez, J., Agredano-Pérez, S., Rubio-Delgado, D. A., Aguilar-Lemarroy, A., Jave-Suárez, L. F., Guevara-Hernández, S. N., Bravo-Cuéllar, A., Méndez-Clemente, A. S., Hernández-Flores, G., & Villaseñor-García, M. M. (2026). Serum Cytokine Profiling in Pancreatic Ductal Adenocarcinoma: A Pilot Study of Candidate Discriminators, Sex Differences and Altered Co-Regulation. Biomolecules. https://doi.org/10.3390/biom16101492

Vancouver

García-Gómez J, Agredano-Pérez S, Rubio-Delgado DA, Aguilar-Lemarroy A, Jave-Suárez LF, Guevara-Hernández SN, et al. Serum Cytokine Profiling in Pancreatic Ductal Adenocarcinoma: A Pilot Study of Candidate Discriminators, Sex Differences and Altered Co-Regulation. Biomolecules. 2026. doi:10.3390/biom16101492

BibTeX
@article{GarcaGmez2026,
  author = {García-Gómez, Jesús and Agredano-Pérez, Samuel and Rubio-Delgado, Diana Alejandra and Aguilar-Lemarroy, Adriana and Jave-Suárez, Luis Felipe and Guevara-Hernández, Sarah Naomi and Bravo-Cuéllar, Alejandro and Méndez-Clemente, Aníbal Samael and Hernández-Flores, Georgina and Villaseñor-García, María Martha},
  title = {Serum Cytokine Profiling in Pancreatic Ductal Adenocarcinoma: A Pilot Study of Candidate Discriminators, Sex Differences and Altered Co-Regulation},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16101492}
}
Kostenlos starten →